| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MATURITAS LetPub Score 6.4
50 ratings
Rate
Reputation 7.6 Influence 5.3 Speed 7.0 | ||||||||||||||||||||
| 期刊簡稱 | MATURITAS | ||||||||||||||||||||
| ISSN | 0378-5122 | ||||||||||||||||||||
| E-ISSN | 1873-4111 | ||||||||||||||||||||
| h-index | 91 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 2.60%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.journals.elsevier.com/maturitas/ | ||||||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/MAT | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | Elsevier Ireland Ltd | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | NETHERLANDS | ||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||
| 創刊年 | 1978 | ||||||||||||||||||||
| 每年文章數 | 193每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 32.28% | ||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-5122%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) 來自Elsevier的數據: Average 4.7 Week(s) | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||
| 在線文章發布時間 | 來自Elsevier的數據: Average 4.9 Week(s) | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [MATURITAS] 的評論 | 撰寫評論 |
| 作者: 陈之鹏 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-06-08 17:03:45 評論於 Maturitas is a very cost-effective SCI journal, suitable for those who seek stability, savings, and require publication in the second quartile. There is no page fee, and the acceptance process takes 2-3 months, faster than most second quartile medical journals, and not dragging on. |
| 作者: 京城赛赛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-22 22:10:59 評論於 Hello, have you replied? |
| 作者: 雪兰超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-17 23:29:08 評論於 How long does it take from submission to the first response? I submitted in August and it is still under review. Is this normal? |
| 作者: 爱宝小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-07 16:10:11 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Sharing Experience: It took over 5 months from submission to acceptance, with a major revision and a minor revision, requiring a high level of language proficiency |
| 作者: 如来芸熙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 13:04:22 評論於 How long does the review time usually take? I am in a hurry to graduate. Can I still submit? |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-29 11:40:38 評論於 It's too easy, let's step it up a bit, isn't it just breaking 3 points? It's really difficult |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-03-19 20:23:17 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: The quality of this journal has improved in recent years and it is considered a mid-level journal in the field of gynecology. The review process usually takes about one month and there is a focus on language issues. The acceptance rate for submissions is 30%-40% |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-28 17:21:32 評論於 Can we reach 3 points next year? Let's discuss |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us